Clinical TrialsSearch results
Number of results: 917
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A phase I study of M875(single-dose study and food-effect study)
- Oral lichen planus
- Fujimoto Souichi
- 2024-10-02
Recruiting
- A Phase I study of SCD-044
- Psoriasis, Atopic dermatitis
- Toida Tsuneyuki
- 2024-07-03
Other
- A phase I trial of unrelated bone marrow transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan.
- 2008-09-08
Completed
- A PHASE I, TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF RAY121 IN HEALTHY VOLUNTEERS
- Healthy Volunteer
- Kai Megumi
- 2022-08-04
Other
- A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer
- small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantation
- Standard primary treatment-refractory acute GVHD
- JCR pharmaceuticals Co.,Ltd
- 2009-02-19
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
- Symptomatic intrapelvic malignant tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)
- Symptomatic metastatic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07